Pfizer News

Pfizer Inc. has been asked to pay more than $15,000 in fines related to workplace violations discovered at its Groton campus, the Hartford office of the U.S. Occupational Safety & Health Administration confirmed this week.

Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp, and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.

Next > Health Canada is still in discussions with Pfizer Inc., about whether to add safety warnings to packages containing anti-smoking drugs that may have psychiatric side effects, including suicidal thoughts.

A San Diego-based investment group is negotiating with Pfizer Inc. to buy the pharmaceutical company's vacant office building at the northeast corner of Romence and Portage roads.

Pfizer Inc. launched Wednesday a program to help newly unemployed Americans who have no prescription drug coverage and who no longer have the financial means to continue receiving medications made by Pfizer.

The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.

Pfizer Inc.'s takeover of Wyeth has run into a roadblock in Europe, but the New York-based pharmaceutical giant has promised changes in an attempt to gain regulatory approval.

French drugmaker Sanofi-Aventis SA on Tuesday announced a major corporate restructuring on the heels of new safety concerns that could hurt sales of a key drug, its once-a-day insulin Lantus.

Rigel Pharmaceuticals Inc's experimental oral treatment for rheumatoid arthritis would hold its own against a rival drug in development at Pfizer and has the potential to be a multi-billion dollar business, a top company official said.

A Nebraska inmate serving time for his girlfriend's murder is the latest person to blame an antidepressant for influencing deadly behavior, but it remains unclear how far the case might go.

The board of directors of Pfizer Inc today declared a 16-cent third-quarter 2009 dividend on the company's common stock, payable September 2, 2009, to shareholders of record at the close of business on August 7, 2009.

Dealmakers saw business pick up again in the second quarter as they helped companies raise cash in capital markets, but lucrative mergers and acquisitions languished.

A 25-year-old inmate who strangled his girlfriend is now suing a drug company. The inmate alleges the antidepressant he was taking led to his losing control.

A group of large corporations says it will help Washington fight the spread of HIV and AIDS with campaigns that include appearances by professional basketball players.

Since 2002, David and Tom Gardner have returned 27.84% while the S&P 500 returned -11.25%. Try Stock Advisor free for 30 days.

GBC's innovative campaign, the U.S. HIV Initiative, combines the private sector's unique skills, expertise and resources with national HIV/AIDS efforts, as well as those run by local governments and non-profits. The campaigns will educate millions of at-risk Americans about the disease to help prevent its further spread, and encourage them to get ...

MannKind Corporation today announced that it has completed its acquisition from Pfizer Inc.

Pfizer Inc will use acquisitions and partnerships in an effort to become the number one drug seller in emerging markets such as China.

The New London Development Corp. must actively pursue developers for the Fort Trumbull peninsula and not sit back hoping investors come calling and a museum gets built.

If you invest with your heart, then MannKind is a great story. Propelled by the will and the bankroll of billionaire chairman and CEO Alfred Mann, this tiny company is striving to make an inhaled form of insulin.